This inventor holds 2 USPTO granted patents. Top assignee: Instrumentation Laboratory. Active years: 1981-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1983
Title: Marvin Feil: Innovator in Blood Gas Control Technologies
Introduction
Marvin Feil is a notable inventor based in Brookline, MA (US), recognized for his contributions to the field of medical technology. He holds 2 patents that focus on blood gas control liquids, which are essential for various medical applications.
Latest Patents
Feil's latest patents include innovative formulations for blood gas control liquids. The first patent describes a blood gas control liquid that comprises a stable oil-in-water emulsion with an oxygen solubility coefficient of at least 10 ml O.sub.2 per 100 ml emulsion and a viscosity of less than 10 centipoises. This emulsion includes water, 5-40 percent by volume of a water-insoluble non-protein compound material, a nonionic surfactant, a pH buffering agent, and a preservative agent that is substantially non-reactive with the pH buffering agent. The preferred formulation has a density of about 1.08 and maintains a pH in the range of 7-8, with specific partial pressures of carbon dioxide and oxygen.
The second patent also focuses on a blood gas control liquid, which consists of water, 5-40 percent by volume of a water-insoluble perfluorinated compound material, and a nonionic, fluorocarbon-based surfactant. This formulation similarly includes a preservative agent and a buffering agent that is non-reactive with the preservative. The blood gas control liquid maintains a pH in the range of 7-8, with defined partial pressures of carbon dioxide and oxygen.
Career Highlights
Marvin Feil has made significant strides in the medical technology sector through his work at Instrumentation Laboratory. His innovative patents have contributed to advancements in blood gas analysis and control, which are critical for patient care in various medical settings.
Collaborations
Feil has collaborated with esteemed colleagues such as Alan D Cormier and Kenneth D Legg, who have also contributed to the field of medical technology. Their combined expertise has fostered an environment of innovation and development.
Conclusion
Marvin Feil's work in blood gas control technologies exemplifies the impact of innovation in the medical field. His patents not only enhance the understanding of blood gas dynamics but also improve patient outcomes through advanced medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile